Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_63700100 Show fit | 6.47 |
ENST00000578993.5
ENST00000259006.8 ENST00000583211.5 |
LIM domain containing 2 |
|
chr15_-_89814845 Show fit | 6.18 |
ENST00000679248.1
ENST00000300060.7 ENST00000560137.2 |
alanyl aminopeptidase, membrane |
|
chr6_-_24911029 Show fit | 5.54 |
ENST00000259698.9
ENST00000644621.1 ENST00000644411.1 |
RHO family interacting cell polarization regulator 2 |
|
chr3_-_13420307 Show fit | 5.20 |
ENST00000254508.7
|
nucleoporin 210 |
|
chr15_+_81196871 Show fit | 4.98 |
ENST00000559383.5
ENST00000394660.6 ENST00000683961.1 |
interleukin 16 |
|
chr5_-_100903252 Show fit | 4.42 |
ENST00000231461.10
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
chr17_-_78717018 Show fit | 4.21 |
ENST00000585509.5
|
cytohesin 1 |
|
chr6_+_391743 Show fit | 4.13 |
ENST00000380956.9
|
interferon regulatory factor 4 |
|
chr3_+_46979659 Show fit | 4.10 |
ENST00000450053.8
|
neurobeachin like 2 |
|
chr15_+_31326807 Show fit | 3.99 |
ENST00000307145.4
|
Kruppel like factor 13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.8 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.9 | 5.5 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.2 | 5.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 4.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 4.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.4 | 4.1 | GO:0045082 | interleukin-13 biosynthetic process(GO:0042231) positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.2 | 4.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.4 | 4.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 4.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 3.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 5.8 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 5.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 5.5 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 4.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 4.3 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 4.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 4.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 3.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 3.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 12.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 7.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 7.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 6.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 5.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 5.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 5.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 4.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 4.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.5 | 4.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 13.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 9.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 9.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 6.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 5.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 5.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 4.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.7 | PID RAS PATHWAY | Regulation of Ras family activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 6.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 5.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 5.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 4.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 3.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |